Stratos Wealth Partners, Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History

Stratos Wealth Partners, Ltd.

$6.14 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$26.2 - $36.08 $42,575 - $58,630	-1,625 Reduced 16.87%	8,010 $215,000
Q2 2023 Jul 18, 2023	BUY	$25.16 - $41.38 $4,906 - $8,069	195 Added 2.07%	9,635 $343,000
Q1 2023 Apr 27, 2023	BUY	$23.68 - $38.51 $26,758 - $43,516	1,130 Added 13.6%	9,440 $239,000
Q4 2022 Jan 19, 2023	BUY	$28.0 - $40.56 $19,320 - $27,986	690 Added 9.06%	8,310 $0
Q3 2022 Oct 24, 2022	SELL	$29.63 - $48.31 $16,148 - $26,328	-545 Reduced 6.67%	7,620 $252,000
Q2 2022 Jul 22, 2022	BUY	$27.79 - $50.61 $16,535 - $30,112	595 Added 7.86%	8,165 $287,000
Q1 2022 Apr 26, 2022	SELL	$39.62 - $69.97 $21,592 - $38,133	-545 Reduced 6.72%	7,570 $348,000
Q4 2021 Jan 14, 2022	SELL	$58.09 - $82.51 $31,949 - $45,380	-550 Reduced 6.35%	8,115 $538,000
Q3 2021 Oct 19, 2021	BUY	$58.38 - $84.96 $75,894 - $110,447	1,300 Added 17.65%	8,665 $541,000
Q2 2021 Jul 19, 2021	BUY	$62.15 - $90.32 $21,441 - $31,160	345 Added 4.91%	7,365 $610,000
Q1 2021 Apr 27, 2021	BUY	$61.35 - $90.47 $32,208 - $47,496	525 Added 8.08%	7,020 $465,000
Q4 2020 Jan 29, 2021	BUY	$43.82 - $85.37 $16,432 - $32,013	375 Added 6.13%	6,495 $498,000
Q3 2020 Oct 29, 2020	BUY	$33.21 - $51.27 $15,608 - $24,096	470 Added 8.32%	6,120 $264,000
Q2 2020 Jul 28, 2020	BUY	$26.12 - $43.27 $147,578 - $244,475	5,650 New	5,650 $244,000
Q1 2020 May 04, 2020	SELL	$20.56 - $63.12 $150,088 - $460,776	-7,300 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$28.14 - $73.01 $5,628 - $14,602	200 Added 2.82%	7,300 $463,000
Q3 2019 Nov 12, 2019	BUY	$26.26 - $34.86 $551 - $732	21 New	21 $242,000
Q3 2019 Nov 12, 2019	BUY	$26.26 - $34.86 $185,894 - $246,773	7,079 Added 33709.52%	7,100 $200,000
Q4 2018 Feb 08, 2019	SELL	$10.74 - $19.7 $69,004 - $126,572	-6,425 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$14.0 - $20.3 $89,950 - $130,427	6,425 New	6,425 $123,000
Q2 2018 Aug 13, 2018	SELL	$6.37 - $14.02 $9,555 - $21,030	-1,500 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$3.14 - $4.5 $4,710 - $6,750	1,500	1,500 $6,000

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

92.3M

Call Options Held

1.33M

Put Options Held

549K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.

Account